tiprankstipranks
Tempest Therapeutics (DE:3OS0)
FRANKFURT:3OS0
Germany Market

Tempest Therapeutics (3OS0) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

3OS0 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Tempest
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

3OS0 Stock 12 Month Forecast

There Are No Analyst Ratings for DE:3OS0 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

3OS0 Financial Forecast

3OS0 Earnings Forecast

Next quarter’s earnings estimate for 3OS0 is -€0.26 with a range of -€0.26 to -€0.26. The previous quarter’s EPS was -€2.19. 3OS0 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year 3OS0 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 3OS0 is -€0.26 with a range of -€0.26 to -€0.26. The previous quarter’s EPS was -€2.19. 3OS0 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year 3OS0 has Performed in-line its overall industry.
No data currently available

3OS0 Sales Forecast

Next quarter’s sales forecast for 3OS0 is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. 3OS0 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year 3OS0 has Performed in-line its overall industry.
Next quarter’s sales forecast for 3OS0 is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. 3OS0 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year 3OS0 has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on DE:3OS0
H.C. Wainwright
H.C. Wainwright
€9.67
Buy
62.79%
Upside
Reiterated
03/31/26
Analysts Offer Insights on Healthcare Companies: Merck & Company (NYSE: MRK) and Tempest Therapeutics (NASDAQ: TPST)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on DE:3OS0
H.C. Wainwright
H.C. Wainwright
€9.67
Buy
62.79%
Upside
Reiterated
03/31/26
Analysts Offer Insights on Healthcare Companies: Merck & Company (NYSE: MRK) and Tempest Therapeutics (NASDAQ: TPST)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
ZURAZura Bio
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tempest Therapeutics

3 Months
PerPlexity BiotechnologyTipRanks - PerPlexity
Success Rate
1/3 ratings generated profit
33%
Average Return
+3.77%
Copying PerPlexity Biotechnology's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of +3.77% per trade.
1 Year
PerPlexity BiotechnologyTipRanks - PerPlexity
Success Rate
1/3 ratings generated profit
33%
Average Return
+3.77%
Copying PerPlexity Biotechnology's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +3.77% per trade.
2 Years
PerPlexity BiotechnologyTipRanks - PerPlexity
Success Rate
1/3 ratings generated profit
33%
Average Return
+3.77%
Copying PerPlexity Biotechnology's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of +3.77% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

3OS0 Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
2
1
1
0
0
Buy
0
0
0
0
0
Hold
22
27
39
63
78
Sell
10
3
3
11
30
Strong Sell
0
0
0
0
0
total
34
31
43
74
108
In the current month, 3OS0 has received 0 Buy Ratings, 78 Hold Ratings, and 30 Sell Ratings. 3OS0 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

3OS0 Stock Forecast FAQ

What is DE:3OS0’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:3OS0’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:3OS0, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Tempest Therapeutics a Buy, Sell or Hold?
      Currently, no data Available
      What is Tempest Therapeutics’s share price target?
      Currently, no data Available
      What do analysts say about Tempest Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Tempest Therapeutics?
      To buy shares of DE:3OS0, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.